Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Patent
1990-03-22
1991-02-12
Raymond, Richard L.
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
549323, C07D30720
Patent
active
049925628
ABSTRACT:
A series of novel polypeptide derivatives, containing 5-amino-2,5-disubstituted-4-hydroxypentanoic acid residues, which are useful for inhibiting the angiotensinogen-cleaving action of the enzyme renin. Particularly valuable precursors for many of these compounds are certain other 5-amino-2,5-disubstituted-4-hydroxypentanoic acid derivatives.
REFERENCES:
patent: 4424207 (1984-01-01), Szelke et al.
patent: 4478826 (1984-10-01), Veber et al.
patent: 4613676 (1986-09-01), Fuhrer et al.
patent: 4661473 (1987-04-01), Boger et al.
patent: 4898977 (1990-02-01), Herold et al.
Rich, J. Med. Chem., 28, 263-273 (1985).
Holladay et al., Tetrahedron Letters, 24, 4401-4404 (1983).
Evans et al., J. Org. Chem., 50, 4615-4625 (1985).
Szelke et al., Proc. Am. Pept. Symp. (8th), 1983, 579-582.
Bindra Jasjit S.
Kleinman Edward F.
Rosati Robert L.
Blackwood Robert K.
Lumb J. Trevor
Pfizer Inc.
Raymond Richard L.
Richardson Peter C.
LandOfFree
Renin inhibitors containing 5-amino-2,5-disubstituted-4-hydroxyp does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Renin inhibitors containing 5-amino-2,5-disubstituted-4-hydroxyp, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Renin inhibitors containing 5-amino-2,5-disubstituted-4-hydroxyp will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-21577